Abstract
Previously, we have developed the in-phantom neutron field assessment parameters T and DTumor for the evaluation of epithermal neutron fields for use in BNCT.1 These parameters are based on an energy-spectrum-dependent neutron normal-tissue RBE2 and the treatment planning methodology of Gahbauer and his co-workers,3 which includes the effects of dose fractionation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.E. Woollard, T.E. Blue, N. Gupta, and R.A. Gahbauer, “Development and Application of Neutron Field Optimization Parameters for an Accelerator-Based Neutron Source for Boron Neutron Capture Therapy”, Nucl. Tech., 155:100–112, (1996).
T.E. Blue, J.E. Woollard, N. Gupta, and R.A. Gahbauer, “Beam Design and Evaluation for BNCT,” Proc. of First Inter. Workshop on Accelerator-Based Neutron Sources for Boron Neutron Capture Therapy, Jackson, WY, Sept. 11–14, 1994, INEL Report Conference-940976, pp. 197–212, (1995).
N. Gupta, R.A. Gahbauer, T.E. Blue, and A. Wambersie, “Dose Prescription in Boron Neutron Capture Therapy,” Int. J. Radiat. Oncol. Biol. Phys., 28:1157–1166, (1994).
H.B. Liu, D.D. Greenberg, J. Capala, and F.J. Wheeler, “An Improved Neutron Collimator for Brain Tumor Irradiations in Clinical Boron Neutron Capture Therapy”, Med. Phys., 23:2051–2060, (1996).
J.A. Coderre, E.H. Elowitz, M. Chadha, R. Bergland, J. Capala, D.D. Joel, H.B. Liu, D.N. Slatkin, and A.D. Chanana, “Boron Neutron Capture Therapy for Glioblastoma Multiforme using p-boronophenylalanine and Epithermal Neutrons: Trial Design and Early Clinical Results”, J. Neuro. Oncol., 33:141–152,(1997).
R.A. Gahbauer, R.G. Fairchild, J.H. Goodman, and T.E. Blue, “RBE in Normal Tissue Studies”, Boron Neutron Capture Therapy: Toward Clinical Trials of Glioma Treatment, D. Gabel and R. Moss (ed), Plenum Press, N.Y., 123–128, (1992).
D.L. Bleuel, S.V. Costes, R.J. Donahue, B.A. Ludewigt, and J. Vujic, “Neutronics Analysis of Three Beam-Filter Assemblies for an Accelerator-Based BNCT Facility”, Proceedings of the Topical Meeting on Nuclear Applications of Accelerator Technology, Albuquerque, NM., Nov. 16–20, 1997, pp. 502–507, (1997).
J.F. Briesmeister (ed.), “MCNP-A General Monte Carlo N-particle Transport Code, Version 4A,” LA-12625, Los Alamos National Laboratory (1993).
D.W. Nigg, F.J. Wheeler, D.E. Wessol, J. Capala, and M. Chadha, “Computational Dosimetry and Treatment Planning for Boron Neutron Capture Therapy”, J. Neuro. Oncol., 33:93–104, (1997).
H. Frankhauser, and P.R. Gavin, “Summing Up: Clinical Papers”, in Advances in Neutron Capture Therapy, A.H. Soloway, R.F. Barth, and D.E. Carpenter (ed), Plenum Press, N.Y., 799–805, (1993).
P.R. Gavin, S.L. Kraft, R. Huiskamp, and J.A. Coderre, “A Review: CNS Effects and Normal Tissue Tolerance in Dogs”, J. Neuro-Oncol., 33:71–80, (1997).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Woollard, J.E., Blue, T.E., Capala, J. (2001). A Comparison of Neutron Fields for BNCT. In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_57
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_57
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive